Literature DB >> 21909720

Discounting, preferences, and paternalism in cost-effectiveness analysis.

Gustav Tinghög1.   

Abstract

When assessing the cost effectiveness of health care programmes, health economists typically presume that distant events should be given less weight than present events. This article examines the moral reasonableness of arguments advanced for positive discounting in cost-effectiveness analysis both from an intergenerational and an intrapersonal perspective and assesses if arguments are equally applicable to health and monetary outcomes. The article concludes that behavioral effects related to time preferences give little or no reason for why society at large should favour the present over the future when making intergenerational choices regarding health. The strongest argument for discounting stems from the combined argument of diminishing marginal utility in the presence of growth. However, this hinges on the assumption of actual growth in the relevant good. Moreover, current modern democracy may be insufficiently sensitive to the concerns of future generations. The second part of the article categorises preference failures (which justify paternalistic responses) into two distinct groups, myopic and acratic. The existence of these types of preference failures makes elicited time preferences of little normative relevance when making decisions regarding the social discount rate, even in an intrapersonal context. As with intergenerational discounting, the combined arguments of growth and diminishing marginal utility offer the strongest arguments for discounting in the intrapersonal context. However, there is no prima facie reason to assume that this argument should apply equally to health and monetary values. To be sure, selecting an approach towards discounting health is a complex matter. However, the life-or-death implications of any approach require that the discussion not be downplayed to merely a technical matter for economists to settle.

Entities:  

Mesh:

Year:  2012        PMID: 21909720     DOI: 10.1007/s10728-011-0188-6

Source DB:  PubMed          Journal:  Health Care Anal        ISSN: 1065-3058


  12 in total

1.  Negative and zero time preference for health.

Authors:  M M Van Der Pol; J A Cairns
Journal:  Health Econ       Date:  2000-03       Impact factor: 3.046

2.  Discounting for health effects in cost-benefit and cost-effectiveness analysis.

Authors:  H Gravelle; D Smith
Journal:  Health Econ       Date:  2001-10       Impact factor: 3.046

3.  An inquiry into the different perspectives that can be used when eliciting preferences in health.

Authors:  Paul Dolan; Jan Abel Olsen; Paul Menzel; Jeff Richardson
Journal:  Health Econ       Date:  2003-07       Impact factor: 3.046

4.  Valuing health--a "priceless" commodity.

Authors:  V R Fuchs; R Zeckhauser
Journal:  Am Econ Rev       Date:  1987-05

5.  Discounting future health benefits: the poverty of consistency arguments.

Authors:  Erik Nord
Journal:  Health Econ       Date:  2010-11-11       Impact factor: 3.046

6.  Discounting costs and effects: a reconsideration.

Authors:  B A van Hout
Journal:  Health Econ       Date:  1998-11       Impact factor: 3.046

7.  Constant and decreasing timing aversion for saving lives.

Authors:  J Cairns; M van der Pol
Journal:  Soc Sci Med       Date:  1997-12       Impact factor: 4.634

Review 8.  Discounting in the economic evaluation of health care interventions.

Authors:  M Krahn; A Gafni
Journal:  Med Care       Date:  1993-05       Impact factor: 2.983

9.  Incorporating societal concerns for fairness in numerical valuations of health programmes.

Authors:  E Nord; J L Pinto; J Richardson; P Menzel; P Ubel
Journal:  Health Econ       Date:  1999-02       Impact factor: 3.046

10.  Personality differences predict health-risk behaviors in young adulthood: evidence from a longitudinal study.

Authors:  A Caspi; D Begg; N Dickson; H Harrington; J Langley; T E Moffitt; P A Silva
Journal:  J Pers Soc Psychol       Date:  1997-11
View more
  5 in total

Review 1.  An Educational Review About Using Cost Data for the Purpose of Cost-Effectiveness Analysis.

Authors:  Matthew Franklin; James Lomas; Simon Walker; Tracey Young
Journal:  Pharmacoeconomics       Date:  2019-05       Impact factor: 4.981

Review 2.  Cost-effectiveness of Colorectal Cancer Screening and Treatment Methods: Mapping of Systematic Reviews.

Authors:  Hossein Mashhadi Abdolahi; Ali Sarabi Asiabar; Saber Azami-Aghdash; Fatemeh Pournaghi-Azar; Aziz Rezapour
Journal:  Asia Pac J Oncol Nurs       Date:  2018 Jan-Mar

Review 3.  Cost-effectiveness of lung cancer screening and treatment methods: a systematic review of systematic reviews.

Authors:  Farbod Ebadifard Azar; Saber Azami-Aghdash; Fatemeh Pournaghi-Azar; Alireza Mazdaki; Aziz Rezapour; Parvin Ebrahimi; Negar Yousefzadeh
Journal:  BMC Health Serv Res       Date:  2017-06-19       Impact factor: 2.655

4.  Cost-effectiveness of adding indoor residual spraying to case management in Afghan refugee settlements in Northwest Pakistan during a prolonged malaria epidemic.

Authors:  Natasha Howard; Lorna Guinness; Mark Rowland; Naeem Durrani; Kristian S Hansen
Journal:  PLoS Negl Trop Dis       Date:  2017-10-23

Review 5.  Discounting in Economic Evaluations.

Authors:  Arthur E Attema; Werner B F Brouwer; Karl Claxton
Journal:  Pharmacoeconomics       Date:  2018-07       Impact factor: 4.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.